Welcome to our dedicated page for FULLER H B CO SEC filings (Ticker: FUL), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
H.B. Fuller Company filings document formal disclosures for a Minnesota-based public company that manufactures and sells adhesives, sealants and chemical-based products. Current reports furnish quarterly and fiscal-year operating results, including revenue, margin, adjusted EBITDA and guidance disclosures tied to pricing, raw-material costs, restructuring savings and acquisition or divestiture effects.
Proxy and governance filings cover annual meeting matters, director elections, auditor ratification, advisory executive-compensation votes, board committee service and director compensation arrangements. The filing record also includes exhibits and Inline XBRL cover data associated with material-event reports.
H.B. Fuller Company director reports deferred stock unit activity. A company director filed a Form 4 showing changes in their equity holdings as of 11/28/2025. Following the reported non-derivative transaction, the director beneficially owned 1,347.1 shares of H.B. Fuller common stock held directly.
The filing also reports an acquisition of 589.82 stock units at a conversion or exercise price of $0.0000 per unit, with each unit convertible into one share of common stock. These units are part of a deferred compensation arrangement and convert into common shares upon retirement, death, disability, or other specified events under the plan. After this transaction, the director held 76,681.06 stock units directly, including units accumulated through a dividend equivalent feature.
H.B. Fuller director reports additional deferred stock units and current holdings. A company director filed a Form 4 for a transaction dated 11/28/2025 involving stock units under the Directors' Deferred Compensation Plan. The filing shows an acquisition of 377.49 stock units with a conversion or exercise price of $0.0000 and an underlying 377.49 shares of common stock, with a reference price of $58.28. These units convert into common stock on a 1-for-1 basis and will be issued upon retirement, death, disability or other specified events under the plan, subject to legal holding periods. After this transaction, the reporting person beneficially owns 29,290.16 stock units directly, as well as 1,351 shares of H.B. Fuller common stock directly.
H.B. Fuller Company (FUL) Executive Vice President and Chief Financial Officer filed a Form 4 reporting equity holdings and a new derivative award. As of the reported transaction on 11/21/2025, the insider beneficially owned 54,646 shares of H.B. Fuller common stock. The filing shows an acquisition of 164.38 phantom units, which are derivative securities that convert into common stock on a 1-for-1 basis under the company’s deferred compensation plan and related terms, bringing total phantom units beneficially owned to 27,527.56 units.
The report also lists multiple employee stock options with exercise prices ranging from $45.05 to $77.72 per share, with expiration dates between 01/24/2027 and 01/27/2035, some of which are fully vested and others vesting in three annual installments of 33%, 33%, and 34%. In addition, the officer holds restricted stock units that convert to common stock on a 1-for-1 basis and vest over three years, with amounts such as 1,302.35, 2,852.64, and 4,370.58 units, including units acquired through dividend equivalent reinvestment.
H.B. Fuller Company (FUL) senior vice president of international growth filed a Form 4 reporting updated ownership of company equity on 11/21/2025. The filing shows 22,316.23 shares of common stock held directly, a balance that includes shares accumulated through a dividend reinvestment plan. It also reports the acquisition of 37.81 phantom units at an exercise price of $0.0000, which convert into common stock on a 1-for-1 basis under a deferred compensation plan, bringing total phantom units beneficially owned to 5,152.6.
The report details multiple employee stock options to buy H.B. Fuller common stock at exercise prices ranging from $51.89 to $77.72, with expiration dates between 01/25/2028 and 01/27/2035. Some of these options are already 100% vested, while others vest in three annual installments of 33%, 33%, and 34%. The filing also lists restricted stock units that convert into common stock on a 1-for-1 basis, vesting over three annual installments and increasing through dividend equivalent reinvestment features.
H.B. Fuller (FUL) reported an insider transaction by its Executive Vice President, Business Transformation. On 11/13/2025, the officer exercised 9,546 stock options at $33.38 per share and sold 7,075 shares at a $58.3771 weighted average price. The sale price range was $58.02–$58.6850. Following these transactions, the officer beneficially owned 9,441 common shares directly.
H.B. Fuller Company (FUL) — Form 144 notice to sell 7,075 common shares. The planned sale is listed through Charles Schwab & Co., Inc. on the NYSE, with an approximate sale date of 11/13/2025 and an aggregate market value of $413,018. The shares were acquired the same day via an employee stock option exercise using a broker-facilitated cashless exercise. Shares outstanding were 54,088,889; this is a baseline figure, not the amount being sold.
H.B. Fuller (FUL) Executive VP and CFO reported insider activity on a Form 4. On 11/07/2025, the officer acquired 162.88 phantom units tied to common stock at a reference price of $57.87. Following this, the officer beneficially owns 27,363.18 phantom units.
The filing also shows 54,646 shares of common stock held directly after the reported activity. In addition, the officer holds multiple employee stock options and restricted stock units with stated vesting and expiration terms, reflecting ongoing equity-based compensation.
H.B. Fuller (FUL) reported insider activity by its Sr. VP, International Growth. On 11/07/2025, the officer acquired 37.47 phantom units (Transaction Code A), which convert into common stock on a 1-for-1 basis under the company plan.
Following the reported transactions, the officer beneficially owned 22,316.23 shares of common stock directly and 5,114.79 derivative units. The filing also lists outstanding employee stock options, including 21,834 options at $53.57 expiring 01/25/2028 and 19,520 options at $51.89 expiring 01/27/2031, alongside restricted stock units that vest in three annual installments beginning on their stated dates.
H.B. Fuller (FUL) Executive VP and CFO reported insider transactions. On 10/27/2025, the officer exercised 16,672 employee stock options at a $43.48 exercise price (code M) and sold 14,222 shares at a $60.3125 weighted average price (code S). After these trades, direct beneficial ownership stood at 54,646 common shares.
Separately, on 10/24/2025, the officer acquired 153.29 phantom units (code A), which convert into common stock on a 1‑for‑1 basis under the Key Employee Deferred Compensation Plan. The filing lists additional vested and time‑based option and RSU awards with stated expiration and vesting schedules.
Sale prices ranged from $60.02 to $60.9350, and the reporting person will provide full pricing details upon request.
H.B. Fuller (FUL) received a Form 144 notice for a proposed sale of 14,222 shares of common stock with an aggregate market value of $857,765.00. The filing lists an approximate sale date of 10/27/2025 on the NYSE through Charles Schwab & Co., Inc.
The shares were acquired on 10/27/2025 via an employee stock option exercise using a broker payment for cashless exercise. Shares outstanding were 54,088,889 at the time cited.